These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cutdowns for totally implantable access ports to central veins. Kulaylat M; Karakousis CP Vascular; 2009; 17(5):273-6. PubMed ID: 19769807 [TBL] [Abstract][Full Text] [Related]
8. A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach. Chen SY; Lin CH; Chang HM; Hsu HM; Yu JC J Surg Oncol; 2008 Sep; 98(3):197-9. PubMed ID: 18704915 [TBL] [Abstract][Full Text] [Related]
9. Internal thoracic vein cannulation as a complication of central venous catheter insertion. Lee AC; Patel JV; Picton SV; Squire R Med Pediatr Oncol; 2003 Mar; 40(3):195-6. PubMed ID: 12518352 [No Abstract] [Full Text] [Related]
10. Totally implantable central venous access devices in adult oncological patients. Florio G; Del Papa M; Mari A; Carnì D Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492 [TBL] [Abstract][Full Text] [Related]
11. Insertion of totally implantable venous access devices: an expertise-based, randomized, controlled trial (NCT00600444). Knebel P; Lopez-Benitez R; Fischer L; Radeleff BA; Stampfl U; Bruckner T; Hennes R; Kieser M; Kauczor HU; Büchler MW; Seiler CM Ann Surg; 2011 Jun; 253(6):1111-7. PubMed ID: 21412146 [TBL] [Abstract][Full Text] [Related]
12. [Venous access using a totally implantable catheter]. Guenier C; Pector JC Rev Med Brux; 1988 Jun; 9(5):274-6. PubMed ID: 3413371 [No Abstract] [Full Text] [Related]
13. Interval between port catheter flushing can be extended to four months. Ignatov A; Ignatov T; Taran A; Smith B; Costa SD; Bischoff J Gynecol Obstet Invest; 2010; 70(2):91-4. PubMed ID: 20224280 [TBL] [Abstract][Full Text] [Related]
14. Long-term venous access using a subcutaneous implantable drug delivery system. Soo KC; Davidson TI; Selby P; Westbury G Ann R Coll Surg Engl; 1985 Jul; 67(4):263-5. PubMed ID: 4037644 [TBL] [Abstract][Full Text] [Related]
15. Open localization technique for percutaneous insertion of central venous access devices. Deshpande RK; Qureshi SS J Surg Oncol; 2007 Jul; 96(1):69-70. PubMed ID: 17567841 [No Abstract] [Full Text] [Related]
16. A novel alternative placement site and technique for totally implantable vascular access ports in non-human primates. Graham ML; Rieke EF; Dunning M; Mutch LA; Craig AM; Zolondek EK; Hering BJ; Schuurman HJ; Bianco RW J Med Primatol; 2009 Jun; 38(3):204-12. PubMed ID: 19220683 [TBL] [Abstract][Full Text] [Related]
17. Editorial regarding use of modified femoral vein approach as method for implanting a totally implantable access port in patients with synchronous bilateral mastectomies (Chen et al.). Wanebo HJ J Surg Oncol; 2008 Sep; 98(3):147. PubMed ID: 18704913 [No Abstract] [Full Text] [Related]
18. Venous access ports: frequency and management of complications in oncology patients. Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390 [TBL] [Abstract][Full Text] [Related]
19. Totally implantable venous access device inserted during major abdominal operations for cancer. A new technique. Di Carlo I; Lombardo R; Russello D; Puleo S Hepatogastroenterology; 2000; 47(34):907-8. PubMed ID: 11020844 [TBL] [Abstract][Full Text] [Related]
20. Managing an implantable drug delivery system. Speechley V; Davidson T Prof Nurse; 1989 Mar; 4(6):284-8. PubMed ID: 2762336 [No Abstract] [Full Text] [Related] [Next] [New Search]